Kaur, Harpreet
Bush, William S.
Letendre, Scott L.
Ellis, Ronald J.
Heaton, Robert K.
Patton, Stephanie M.
Connor, James R.
Samuels, David C.
Franklin, Donald R.
Hulgan, Todd
Kallianpur, Asha R. http://orcid.org/0000-0002-6483-523X
Funding for this research was provided by:
National Institutes of Health (1R01 MH095621, 1R01 MH095621, R01 MH107345, R01 MH107345)
Article History
Received: 12 March 2021
Accepted: 18 May 2021
First Online: 30 June 2021
Declarations
:
: CHARTER is a multi-center study which has received continuous approval by the institutional review boards (IRBs) of all participating institutions/sites. IRB approval numbers can be provided upon request.
: All CHARTER study participants provided written informed consent for the parent study that provided the de-identified CSF samples and data for this analysis.
: All authors provided consent for publication.
: Authors Kaur, Bush, Letendre, Franklin, Ellis, Hulgan, Heaton, Samuels, and Kallianpur have no potential conflicts of interest to disclose. Author S. Patton is a paid consultant for SideroBiosciences, Inc., and J.R. Connor, a longstanding collaborator, is co-founder and Chairman of the Board of SideroBiosciences, which has a product in clinical trials for treating iron deficiency.